Q-Line Biotech was originally incorporated as ‘POCT Services Private Limited’ on November 10, 2010 as a Private limited company. Subsequently, pursuant to a special resolution passed by the shareholders in the Extra-Ordinary General Meeting held on June 12, 2021, the name of the company was changed to ‘Q-Line Biotech Private Limited’. Further, pursuant to a special resolution passed by the shareholders in the Extra-Ordinary General Meeting held on February 19, 2025, the company was converted from a private limited company to public limited company and consequently the name of the company was changed to ‘Q-Line Biotech Limited’.

The company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and In Vitro Diagnostic (IVD) products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medical colleges. The core segments of operations of the company in IVD Industry include Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices & Rapids).

Its key manufacturing segments include indigenous manufacturing of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices & Rapids) and supplying/ manufacturing of in-vitro diagnostics, Pathology equipment’s & devices. Further during the Covid-19 pandemic, the company diversified its focus and with the technical collaboration of third-party institutes and through its own R&D team developed a range of Covid testing kits viz. RT-PCR Kits, RNA Extraction Kits, VTM Kits etc. It is research driven company engaged in developing and manufacturing a wide range of reagents formulations used across various IVD and diagnostic needs. The company leverages its R&D capabilities to develop and manufacture a portfolio of differentiated reagent formulations /products. The company works on a B2B model and supplying most of its products to its customers which includes distributors, diagnostic service providers and hospitals.

Business area of the company 

The company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

Products and services of the company

• Reagent
• Instrument
• Consumable/Spare
• Service

Awards, accreditations and recognition 

• 2022-23: Received the Certificate of Excellence from Boule for outstanding dedication and service to Boule products.
• 2023-24: Received an Appreciation Award at JAI-CON 2023 during the 1st State Level Scientific Conference organized by JAI MLAP Punjab.
• 2023-24: Received the Outstanding Distributor Award 2023 from Shenzhen Lifotronic Technology Co., Ltd. for their professionalism and valuable contribution.
• 2023-24: In-house R&D recognized by Government of India, Ministry of Science and Technology, Department of Scientific and Industrial Research (DSIR).
• 2024-25: Awarded with Certificate of Appreciation for participation in Pharmatech & Health East Africa and Medical & Lab East Africa held in Dar Es Salaam, Tanzania.
• 2024-25: Received the Golden Star Icon Award 2024 for pioneering work in In-Vitro Diagnostics & Associated Equipment.
• 2024-25: Awarded ‘Most Promising Company in IVD for Make in India initiative’ at the 15th MT India Healthcare Awards 2025 by Medgate Today Magazine.

History and milestones

• 2010-11: Incorporation of the company as a Private Limited Company in the name and style of ‘POCT Services Private Limited’ founded by Saurabh Garg, Amita Garg and Pushplata Garg.
• 2014-15: First Branch office at Delhi 20-A Basement, Najafgarh Road, Shivaji Marg, West Delhi, New Delhi - 110015.
• 2016-17: Established the first manufacturing facility at Plot No. 3, Pocket - H, Sector - 5, Bawana Industrial Complex, Bawana, Delhi – 110039, India.
• 2018-19: Incorporated an associate company in the name of ‘POCT Science House Private Limited’.
• 2020-21: Introduced Viral Transport Medium (VTM), Nucleic Acid Extraction Kit and Covid-19 RT-PCR Kit.
• 2020-21: Expanded ELISA product range with HIV, HCV, and HBsAg kits.
• 2021-22: Change of the name of the company from ‘POCT Services Private Limited’ to ‘Q-Line Biotech Private Limited’.
• 2022-23: Expansion of office at Naraina Industrial Area, New Delhi.
• 2023-24: Incorporated a subsidiary company in the name of ‘Q-Line Nutraceuticals Private Limited’.
• 2023-24: Incorporated a subsidiary company in the name of ‘IQ-Line Private Limited’.
• 2023-24: Incorporated an associate company in the name of ‘Q-Line Iris Private Limited’.
• 2023-24: Established the manufacturing facility at Plot No. 276, Behtwa, Amausi, Station Road, Sarojni Nagar, Lucknow, Lucknow - 226009, Uttar Pradesh.
• 2023-24: Established the manufacturing facility at Plot No. 3105, Gindan Khera, Amausi Station Road, Nadarganj, Lucknow226008, Uttar Pradesh.
• 2023-24: Transferred its entire shareholding in ‘IQ-Line Private Limited’ which resulted in it no longer being a subsidiary company.
• 2024-25: Established the manufacturing facility in 298 and 281, Adjacent Transport Nagar Metro station, Transport Nagar, Lucknow - 226023, Uttar Pradesh.
• 2024-25: Conversion of the Private Limited Company into a Public Limited Company as per the provisions of the Companies Act, 2013.
• 2024-25: Acquired shares in ‘Q-line Innovations Private Limited’, making it a subsidiary company.
• 2024-25: Transferred its entire shareholding in ‘Q-Line Nutraceuticals Private Limited’ which resulted in it no longer being a subsidiary company.
• 2024-25: Transferred its majority shareholding in ‘POCT Science House Private Limited’ which resulted in it no longer being an associate company.